Higher-Dose Ivermectin No Better Than Standard Dose for Severe Scabies
Medically reviewed by Drugs.com
via HealthDayFRIDAY, May 8, 2026 -- For adults with severe scabies, higher-dose ivermectin plus permethrin is not superior to standard-dose ivermectin plus permethrin, according to a study published in the May 7 issue of the New England Journal of Medicine.
Charlotte Bernigaud, M.D., Ph.D., from the Hôpital Henri-Mondor in Créteil, France, and colleagues conducted a blinded randomized trial involving adults with severe scabies to examine the combination of higher- versus standard-dose oral ivermectin and topical scabicides for treatment. Patients were randomly assigned to receive ivermectin 400 μg/kg body weight (higher-dose group) or 200 μg/kg body weight (standard-dose group) on days 0, 7, and 14, combined with head-to-toe application of 5 percent permethrin cream on days 0 and 7 and daily application of emollient cream.
The main analysis included 132 patients (66 in each group). The researchers found that 75 and 82 percent of patients in the higher- and standard-dose groups, respectively, had cure of severe scabies, defined as absence of mites and mite-related products on days 18 and 21 and the absence of active clinical lesions on physical examination on day 28 (odds ratio for cure, 0.64; 95 percent confidence interval, 0.25 to 1.67). There were no safety issues.
"Beyond showing that a higher dose of ivermectin was no better than the standard dose in curing severe scabies, the results of our trial show that repeated administration of oral ivermectin at a dose of 200 μg per kilogram, combined with topical application of 5 percent permethrin and an emollient cream (with or without keratolytic agents), could be used for profuse and crusted scabies," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-09 02:11
Read more
- Update on FDA Advisory Committee Vote on Camizestrant in Combination with a CDK4/6 Inhibitor for Advanced HR-Positive Breast Cancer
- FDA Approves Dupixent for Chronic Spontaneous Urticaria in Young Children
- PAS: Balanced Crystalloid Fluid, 0.9 Percent Saline Comparable in Pediatric Septic Shock
- ACP Updates Breast Cancer Screening Recommendations
- Prevalence of Selected Complementary Health Approaches High in Seniors
- Bullying, Politics Harm Mental Health Of Gender-Diverse Teens
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions